S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection. (October 2021) - Allegretti, Jessica R.; Kelly, Colleen R.; Louie, Thomas; Fisher, Monika; Hota, Susy; Misra, Bharat; Van Hise, Nicholas W.; Yen, Eugene F.; FACG,; Bullock, Jeff S.; Pullman, John; Nathan, Richard; et al.